Moderna’s Cancer Factory Is the Real Story
A Phase 3 melanoma win proves mRNA oncology. Can it scale?
World’s greatest investor makes his final bet
September 18, 2026 Bonus Content: Raiffeisen Fell 9% on a Short-Seller’s Russia Allegations. Here Is What That Actually Costs. A…
The EV Company Up 9% Still Down 60%
September 18, 2026 Bolt aims for 25,000 European robotaxis and AlixPartners is gone, but the balance sheet math still matters….
Elon’s Big 2026 Warning
September 18, 2026 Bonus Content: Orion180 Priced Its IPO at $12. The Range Was $15 to $17. A note from…
Zcash Hits $1,400 While Bitcoin Loses Ground in 2026
The Fed’s first rate hike since 2023 barely dented ZEC. Bitcoin still can’t reclaim its January open.
Intuitive Surgical Is 37% Off Its High. Recurring Revenue Says That Gap Is Wrong.
Five straight quarters of beating estimates, 85% recurring revenue, and a decade-low multiple are the case for ISRG right now.
410 new millionaires a day?
A note from our friends at The Oxford Club(ad) Reader, If my math is correct, what I’m about to reveal…
The Travel Stock Wall Street Just Punished
September 17, 2026 Morgan Stanley restarted OTA coverage and put Expedia last. Engagement math makes it hard to argue back….
Holtec Nuclear Pulled Its $900 Million IPO. Still Worth Watching.
HNUC shelved its listing as the Fed hiked, and its real revenue base sets it apart.
This Goes Back to $29.97
September 17, 2026 Bonus Content: Private Equity Is Circling Ashland. Can It Pay What the Activist Says It’s Worth? A…